SANUWAVE Health, Inc.

30.44-0.60 (-1.93%)
Oct 29, 4:00:00 PM EDT · NasdaqGM · SNWV · USD

Upcoming Earnings

Report date
≈ Nov 7, 2025 (in 8 days)

Key Stats

Market Cap
260.81M
P/E (TTM)
-
Basic EPS (TTM)
-8.22
Dividend Yield
0%

Recent Filings

About

SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and chronic wounds. It also markets PACE systems that use acoustic pressure shockwaves generated by pulsed acoustic cellular expression technology to converge at selected areas for wound and orthopedic applications under the dermaPACE, Profile, and orthoPACE brand names. The company was founded in 2004 and is headquartered in Eden Prairie, Minnesota.

CEO
Mr. Morgan C. Frank
IPO
10/18/2024
Employees
46
Sector
Healthcare
Industry
Medical Devices